NEOVASCULARISATION

This adverse event was reported 263 times

NEOVASCULARISATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FROVATRIPTAN SUCCINATE 55 0.0689
1 DIHYDROERGOTAMINE MESYLATE 40 0.0297
2 VERAPAMIL HYDROCHLORIDE 35 0.0081
3 RIZATRIPTAN BENZOATE 61 0.0059
4 DIMENHYDRINATE 62 0.0058
5 CASTOR OIL 1 0.0052
6 TETRACAINE 2 0.0051
7 FOSFOMYCIN TROMETHAMINE 3 0.0049
8 BOTULINUM TOXIN TYPE A 59 0.0046
9 ALLOPURINOL SODIUM 2 0.0035
See all drugs enriched for association with NEOVASCULARISATION